Patrick Ziegler
Impact in
- Aging top 5%
- Hematology top 5%
- Hematopoietic Stem Cell Transplantation
Papers in
-
- Toxic Organic Pollutants Impact 15
- Effects and risks of endocrine disrupting chemicals 6
-
- Carcinogens and Genotoxicity Assessment 12
- Co-authors
- Wolfgang Wagner (5 shared papers)Tim H. Brümmendorf (14 shared papers)Fabian Beier (9 shared papers)Qiong Lin (3 shared papers)Martin Zenke (3 shared papers)Carmen Koch (2 shared papers)Raimund Erbel (1 shared paper)Lewin Eisele (1 shared paper)
- Journals
- Archives of Toxicology (6 papers)Blood (5 papers)Annals of Hematology (3 papers)Investigational New Drugs (2 papers)Scientific Reports (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
Patrick Ziegler
57 papers receiving 1.9k citations
Patrick Ziegler's Hit Papers
Peers
Comparison fields: 5 of 132
- Aging 80
- Hematology 253
- Virology 101
- Genetics 207
- Molecular Biology 974
Countries citing papers authored by Patrick Ziegler
This map shows the geographic impact of Patrick Ziegler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Patrick Ziegler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Patrick Ziegler more than expected).
Fields of papers citing papers by Patrick Ziegler
This network shows the impact of papers produced by Patrick Ziegler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Patrick Ziegler. The network helps show where Patrick Ziegler may publish in the future.
Co-authors
The 25 scholars most cited alongside Patrick Ziegler, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 61 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Aging of blood can be tracked by DNA methylation changes at just three CpG sites Hit paper breakdown → | 2014 | 689 |
| 2 | 2011 | 161 | |
| 3 | 2012 | 119 | |
| 4 | 2012 | 104 | |
| 5 | 2009 | 100 | |
| 6 | 1999 | 52 | |
| 7 | 2013 | 51 | |
| 8 | 2012 | 46 | |
| 9 | 2016 | 45 | |
| 10 | Inhibition of Cell Growth of the Prostate Cancer Cell Model LNCaP by Cold Atmospheric Plasma. | 2016 | 40 |
| 11 | 2020 | 37 | |
| 12 | 2015 | 35 | |
| 13 | 2012 | 32 | |
| 14 | 2020 | 26 | |
| 15 | 2017 | 24 | |
| 16 | 2016 | 24 | |
| 17 | Heat-shock protein HSPB1 attenuates microRNA miR-1 expression thereby restoring oncogenic pathways in prostate cancer cells. | 2014 | 23 |
| 18 | 2015 | 22 | |
| 19 | 2015 | 20 | |
| 20 | 2018 | 19 |
About Patrick Ziegler
Patrick Ziegler is a scholar working on Health, Toxicology and Mutagenesis, Cancer Research, Hematology, Physiology and Molecular Biology, having authored 61 papers that have together received 2.0k indexed citations. Recurring topics across this work include Toxic Organic Pollutants Impact (15 papers), Carcinogens and Genotoxicity Assessment (12 papers), Telomeres, Telomerase, and Senescence (9 papers), Acute Myeloid Leukemia Research (7 papers), Hematopoietic Stem Cell Transplantation (6 papers), Effects and risks of endocrine disrupting chemicals (6 papers), Pharmacogenetics and Drug Metabolism (5 papers) and Chronic Myeloid Leukemia Treatments (5 papers). The work is most often cited by research in Aging (80 citations), Hematology (253 citations), Virology (101 citations), Genetics (207 citations) and Molecular Biology (974 citations). Patrick Ziegler has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include Wolfgang Wagner, Tim H. Brümmendorf, Fabian Beier, Qiong Lin, Martin Zenke, Carmen Koch, Raimund Erbel, Lewin Eisele, Dirk Bauerschlag and Thomas W. Mühleisen. Their work appears in journals such as Archives of Toxicology, Blood, Annals of Hematology, Investigational New Drugs and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.